This paper delves into the application and prospects of bio-antibiotics and mRNA vaccines in preventing and treating bacterial infections and infectious diseases. Against the backdrop of the increasingly serious antibiotic resistance issue, the effectiveness of traditional antibiotic treatments is challenged, while bio-antibiotics and mRNA vaccines, as novel treatment methods, are emerging. Bio-antibiotics, derived from organisms or bioengineered, possess advantages such as antibacterial activity, biocompatibility, low toxicity, and reduced resistance risk, showing broad prospects in treating multi-drug-resistant bacteria infections, special types of infections, and preventive medication. mRNA vaccines, by introducing mRNA encoding pathogen antigens to stimulate the human immune response, are characterized by rapid development, high efficiency, and safety, playing a crucial role in infectious disease prevention and control, especially during the COVID-19 pandemic when the successful development and widespread application of mRNA vaccines significantly reduced the infection rate and mortality. The article also analyzes successful cases of bio-antibiotics and mRNA vaccines in practical applications and the challenges they face, such as extraction and purification techniques, stability, delivery systems, long-term safety, and regulatory policies, and proposes future research directions and prospects. In conclusion, bio-antibiotics and mRNA vaccines, as novel treatment, have great application potential and will bring new hope and opportunities to the global public health field.
Read full abstract